8.30AM - 5.30PM EST | 5.30AM - 2.30PM PST

8:30 am Virtual Coffee & Networking

8:50 am Chair’s Opening Remarks

Investigating Novel Inflammasome Inhibitors

9:00 am Determining the Mechanism of Action of Inflammasome Inhibitors

  • Rebecca Coll Principal Investigator,
    Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast

9:30 am Exploring the use of Bioluminescent Resonance Energy Transfer to Depict the Mechanism of Action of Novel Inflammasome Inhibitor

  • Pablo Pelegrin Scientific Deputy Director & Principal Investigator, Biomedical Research Institute of Murcia

10:00 am Live Q&A

  • Rebecca Coll Principal Investigator,
    Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast
  • Pablo Pelegrin Scientific Deputy Director & Principal Investigator, Biomedical Research Institute of Murcia

Synopsis

Have the speaker answer your questions

10:20 am Morning Refreshments & Virtual Speed Networking

11:20 am

1:10 pm Networking & Lunch

OUTSIDE NLRP3 – Where do we Stand?

2:00 pm Ic100: A Novel Anti-Asc Monoclonal Antibody Improves Functional Outcomes in an Animal Model of Multiple Sclerosis

  • Robert Keane Professor, Physiology, Biophysics & Neurological Surgery, University of Miami

2:30 pm Recent Insights into NLRP1 and CARD8 Inflammasome Activation

3:00 pm Targeting Multiple Inflammasomes with IC100, a Monoclonal Antibody Against ASC

3:30 pm Live Q&A Session

Synopsis

Have the speakers answer your questions

3:50 pm Networking & Afternoon Refreshments

Delving into the Detail of Cytokine Pathways & Cell Death

4:20 pm Exploring ASC Speck Formation & NET Formation

4:50 pm Inflammasome Signalling & Regulation of Cytokines

  • Kate Schroder Director IMB Centre for Inflammation and Disease Research, The University of Queensland

5:20 pm Live Q&A Session

  • Denisa D. Wagner Professor, Paediatrics, Boston Children’s Hospital
  • Kate Schroder Director IMB Centre for Inflammation and Disease Research, The University of Queensland

Synopsis

Have the speakers answer your questions

5:40 pm Chair’s Closing Remarks